News & Announcements

A recent study by Nadav Ahituv, PhD, showed that obesity caused by a gene mutation could be treated in animal models.

Fraser developed several new tools for creating maps of macromolecules, a critical first step for finding new drugs.

Many types of lung cancer thwart even the most targeted of therapies due to drug resistance, but a group of UCSF scientists led by Sourav Bandyopadhyay, PhD, have now shown that adding a second drug into treatment regimens can overcome this resistance in lab-grown, lung cancer cell lines.

Tuberculosis is usually treated with a six month regimen of daily antibiotics, but millions of patients do not recover from the disease during treatment. Rada Savic’s team showed that adjusting the duration of this regimen based on disease severity could lead to better outcomes.

Drug discovery today begins with computation rather than test tube experimentation. Three School of Pharmacy faculty emeriti, Robert Langridge, Irwin “Tack” Kuntz, and the late Peter Kollman, were awarded the UCSF Medal for creating computational tools for drug discovery that are now used worldwide.

Curriculum transformation, An expanded role, Gaining recognition, Graduate match rate; School of Pharmacy scientists receive UCSF Medal: Founding fathers of drug discovery honored; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients; Advancing the fight against cancer, Combining drug therapies, Mapping cells; In memoriam: Robert D. Gibson A lifetime of pharmacy and advocacy

UCSF’s Quantitative Biosciences Institute (QBI), founded two years ago, is making waves with its unique approach to scientific collaboration, catalyzing discoveries from cancer to psychiatry while supporting female scientists and engaging with the public.

Health at the molecular level: Decoding cellular signals, A trigger for tissue repair, Seeding tomorrow’s science. The future of custom care: Tracking cancer drug resistance, Treating malaria and tuberculosis, Quantitative Biosciences Institute’s culture of inclusivity, The genetics of asthma. Ensuring the best possible care: Using the right drugs, Keeping up with the testing boom. Update on the new PharmD curriculum: Welcoming our new students at the end of July. And more.

Sessions include: quickly identifying molecules that show potential as drugs; improving access and treatments for AIDS, malaria, and tuberculosis; why curiosity and imagination are taking the place of memorization the PharmD curriculum. Honoring the Class of 1968. Kennedy receives Distinguished Alumnus of the Year Award.

UCSF School of Pharmacy scientists, across all three departments and in widely divergent fields, are continually questioning the status quo.

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

The 122 members of the graduating class of 2018 received their PharmD degrees at commencement.

Yiqi Cao, a bioengineering PhD candidate, detailed a promising solution she developed for a heart stent that doesn’t trigger scar tissue buildup.

Andrej Sali, PhD, has been elected as a member of the 2018 class of the National Academy of Sciences (NAS).

The UCSF Asthma Collaboratory celebrates 20 years of research on genetic factors in asthma.